SlideShare une entreprise Scribd logo
1  sur  59
Télécharger pour lire hors ligne
DIAGNOSIS & TREATMENT
OF PARKINSON’S DISEASE
May 7, 2008
Sadhana Prasad
Symposium on Changes and Challenges in
Geriatric Care Brought to you by
Disclosures
• Work with various pharmaceutical
companies intermittently
• Honorarium will be donated
Brought to you by
Brought to you by
Brought to you by
OBJECTIVES
1. Illustrate medications and
conditions that may mimic PD
2. Describe the early symptoms of Parkinson’s
Disease (PD)
3. Discuss initiating and stopping medications
Brought to you by
Parkinson’s Disease
Characterized by: (Slow,Stiff,Shaky)
• Bradykinesia *
• Rigidity *
• Rest tremor--3-6Hz pill-rolling (absent 1/3)
• Postural instability
Brought to you by
Parkinson’s Disease (PD)
• First description 1817
Parkinson, James An Essay on the Shaking Palsy, Sherwood, Neely, and Jones,
London
• Progressive neurodegenerative disease
• Affects ages 40 onwards, mean age at
diagnosis 70.5
• Complex disorder with motor, non-motor,
neuropsychiatric features
Brought to you by
Disease vs Syndrome
• Disease = a morbid process having
characteristic symptoms; pathology,
etiology, and prognosis may be known
• Syndrome = a set of symptoms occurring
together; different etiologies but similar
presentation
Brought to you by
Parkinson’s Syndromes
Metabolic causes--
• Hypothyroidism
• Hypoparathyroidism
• Alcohol withdrawl (pseudoparkinsonism)
• Chronic liver failure
• Wilson’s disease
Brought to you by
P. Syndromes
Medications**/chemicals—
• neuroleptics (typicals more than the atypicals),
• SSRI (selective serotonin reuptake inhibitors),
• metoclopromide/maxeran,
• Reserpine,
• MPTP,
• in Methcathinone (ephedrone) users – high
plasma Manganese levels (NEJM Mar 6, 2008)
• CO, cyanide, organic solvents, carbon disulfide
Brought to you by
P. Syndromes
Structural Causes—
• Strokes
• Tumors
• Chronic subdurals
• NPH (Normal Pressure Hydrocephalus)
Brought to you by
P.Syndromes
Lewy Body spectrum of Diseases
(DLB=Dementia with LB)---
---early onset visual (or other) hallucinations
---fluctuating cognitive abilities
---sleep disorders
---neuroleptic sensitivity, even to atypicals
Brought to you by
P. Syndromes
PSP (progressive supranuclear palsy)—or
Steeles Richardson Olszewski Syndrome
---gaze abnormalities
---postural instability, early unexplained falls
---bulbar features—dysphonia, dysarthria,
dysphagia
---rapidly progressive---median 6 yrs.
Brought to you by
P. Syndromes
CBD (cortico basal degeneration)---
---Asymmetric parkinsonism
---postural instability
---ideomotor apraxia
---aphasia
---alien limb phenomenon
---impaired cortical sensations
Brought to you by
P. Syndromes
Multi System Atrophy-- (alpha-synuclein +
glial cytoplasmic inclusions, autonomic
dysfunction, pyramidal signs)
• Shy Drager Syndrome,
• Olivopontocerebellar atrophy,
• Striatonigral degeneration
Brought to you by
P. Syndromes
Other Neurodegenerative Disorders—
• Alzheimer’s Disease, later stages**
• Huntington’s Disease (rigid form)
• Frontotemporal Dementia with
Parkinsonism, Chromosome-17 linked
(FTDP-17)
• Spinocerebellar ataxias
Brought to you by
P. Syndromes
Infections---
• encephalitis
• HIV/AIDS
• Neurosyphilis
• Toxoplasmosis
• CJD (Creuzfeld Jakob)--prion disease
• Progressive multifocal
leukoencephalopathy
Brought to you by
P. Syndrome
Essential Tremor---
---action tremor (not rest tremor)
---more rapid (greater than 3-6 Hz)
---usually hands, but can also affect legs,
head/chin, voice, trunk
---can present with falls if legs and trunk
involved
Brought to you by
P. Disease
??DIAGNOSIS??
Brought to you by
P. Dis -- Diagnosis
• A clinical diagnosis
• Cardinal features: Bradykinesia, rigidity
• Trial of sinemet (Levodopa/carbidopa)
• Confirmatory test: neuropathologic
(autopsy)
Brought to you by
P. Disease-Diagnosis
• 1/3 will not respond to levodopa therapy
• 1/5 with P. Syndrome will respond to
levodopa
---Follow- up with time needed to clarify
diagnosis
Brought to you by
P. Disease---Diagnosis
Minimum therapeutic dose:
---300mg levodopa per day in divided doses
---can be lower in biologically old old
---vast majority will need 400-600mg
levodopa daily to achieve significant
benefit
Brought to you by
P. Disease- Diagnosis
Consider alternative diagnosis if:
• Early falls (postural instability)
• Poor response to levodopa
• Dysautonomia (urinary retention/atonic
bladder, incontinence, orthostatic
hypotension, impotence)
• No rest tremor (in 1/3)
Brought to you by
P. Disease-Diagnosis
Alternative Diagnosis cont’d…
• Cerebellar signs
• Positive Babinski
• Apraxia
• Gaze abnormailities
• Dementia concurrently with Parkinsonism
• Strokes
Brought to you by
P. Disease
INVESTIGATIONS:
• TSH
• Calcium, albumin
• CT head
Brought to you by
OBJECTIVES
1. Illustrate medications and conditions that may
mimic PD
2. Describe the early
symptoms of Parkinson’s
Disease (PD)
3. Discuss initiating and stopping medications
Brought to you by
PD- CASE
• Mr AB, married, active farmer, stressed
care-giver
• Drove his wife to the clinic, wife to see me
re agitated dementia
• One son also attended
• Mr AB –stressed care-giver, on paxil
(SSRI)
Brought to you by
PD- case
Mr. AB--- stressed caregiver
• Slightly flexed posture
• Slightly bradykinetic
• Slightly diminished facial expression
• No difficulty turning, getting in/out of
armless chair
Brought to you by
PD-case
“I don’t have Parkinson’s Disease!!”
Brought to you by
PD- case
Mr. AB---
• 1 month later, referred re ? PD??
• CT head, TSH, Ca normal
• Slowing down x 1 yr, hypophonia, denied
trouble turning in bed but took 5 tries in
clinic, trouble getting out of soft chair,
stopped taking baths x 3 years, mild rest
tremor R hand, trouble doing up buttons
and laces
Brought to you by
IADL
Instrumental Activities of Daily Living
• S shopping
• H housework
• A accounting
• F food preparation
• T transportation
Brought to you by
ADL
Activities of Daily Living
• D dressing
• E eating
• A ambulation
• T toiletting
• H hygiene
Brought to you by
PD- case 1
Brought to you by
PD-case 1
clock
Brought to you by
PD –Case 1
Diagnosis:
Parkinson’s disease ---Hoehn & Yahr’s**
stage 2
Brought to you by
Hoehn and Yahr scale
• 1. Unilateral involvement only, usually with minimal or
no functional disability
• 2. Bilateral or midline involvement without impairment of
balance
• 3. Bilateral disease; mild to moderate disability with
impaired postural reflexes; physically independent
• 4. Severely disabling disease; still able to walk or stand
unassisted
• 5. Confinement to bed or wheelchair unless aided
Hoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology 1967;
17:427.
Brought to you by
PD- case 1
• MTO notified, “not to cancel license”
• Paxil *
• Sinemet regular 100/25 mg ½ tid, increase
by ½ weekly till 1 tid
• Calcium and vitamin D3
• 2 months later, smiling, clock better,
moving better, still flexed, no fallsBrought to you by
PD-case 1
clock
Brought to you by
PD—other issues
• Depression
• Dementia
• Driving
• Falls
• Neuropsychiatric features
• “slowing down of thought processes” (the
clock in Mr AB)
• Constipation
Brought to you by
PD-Treatment
????
Brought to you by
OBJECTIVES
1. Illustrate medications and conditions that
may mimic PD
2. Describe the early symptoms of
Parkinson’s Disease (PD)
3. Discuss initiating and
stopping medications
Brought to you by
PD--Treatment
• Geared towards mobility—levodopa, dopamine
agonists, MAO B inhibitors
• Rest tremor, cosmetic—anticholinergics (may
worsen cognition)
• Postural imbalance—no pharmacological
treatment; exercise, gait aids, prevent fractures
(Ca, Vit D3, +/- bisphosphonates)
• Dyskinesias-- ?amantadine (no clear evidence)
Almeida,QJ, Recent Patents on CNS Drug Discovery, 2008:3, 5--54
Brought to you by
PD--Which pharmaceutical?
In Elderly--
• Levodopa/ carbidopa (sinemet) – regular
vs CR (controlled release)
or
Levodopa/ benserazide (prolopa) – regular
vs HBS
• COMT- inhibitor– entacapone (comtan)Brought to you by
PD- medications
LevodopaLevodopa
• Well-established, for bradykinesia and
rigidity
• SE: nausea, orthostatic hypotension
• Combined with peripheral decarboxylase
inhibitor (carbidopa, benserazide) to
prevent conversion to dopamine in the
periphery before it crosses blood brain
barrier
Brought to you by
PD- medications
Levodopa (l-dopa)
-- l-dopa / carbidopa = sinemet reg. or CR
-- l-dopa / benserazide = prolopa, medopar or
medopar HBS
• Competes with amino acids from protein for GI
absorption
• Regular-- before meals, quick in quick out, T1/2
= 90 min
• CR--- With meals,Controlled Release, slow in
slow out, need 30% more to achieve same effect
as reg. dose, erratic absorption in elderly
Brought to you by
PD-medications
L-dopa cont’d
• SE- Nausea (Rx Domperidone)
-Hallucinations (Rx lower dose, atypical
n neuroleptics)
-somnolence, confusion, agitation
-motor fluctuations- after sev yrs of Rx
Brought to you by
PD- medications
L-dopa cont’d
• Motor fluctuations (in 50%, after 5-10yrs)
-wearing-off– Rx COMT – inhibitor*, ?CR
-dyskinesias –(??Rx amantadine??)
-dystonias
-variety of complex fluctuations in motor
function
Brought to you by
PD- medications
L-dopa cont’d
• Discontinuation—
- gradually –over weeks,
- to prevent malignant neuroleptic like
syndrome or akinetic crisis
Brought to you by
PD-medications
L-dopa cont’d
• Dopaminergic dysregulation syndrome (DDS)—
tolerance to mood elevating effects
- Compulsive use of dopaminergic drugs
- Early onset males
- Cyclical mood disorder
- Impulse control disorder (hypersexuality,
pathologic gambling)
Giovannoni, G, Hedonistic homeostatic dysregulation…J. Neurol Neurosurg Psychiatry
2000; 68:243
Brought to you by
PD- medications
COMT – inhibitorCOMT – inhibitor
-Catechol-O-Methyl Transferase Inhibitor
-((eg Tolcapone (Tasmar)---off market due to
fulminant hepatitis causing 3 deaths))
-eg Entacapone (Comtan)
-for wearing-off at end-of-dose of L-dopa
-dose 200mg-1600mg, divided, daily, with L-dopa
-SE-diarrhea in 5%, due to increased
dopaminergic stimulation from L-dopa
availability Brought to you by
PD-medications
Dopamine Agonists: adjunct Rx to L-dopa.
-Ergotamines—bromocriptine, ((pergolide)),
((cabergoline))
SE-same as L-dopa, uncommon Raynaud’s,
erythromelalgia, retroperitoneal/pulmonary
fibrosis
-Non-Ergot—pramipexole, ropinirole, ((transdermal
rotigotine))
SE—same as L-dopa, Sudden somnolence –
caution with driving
Brought to you by
PD-medications
MAO-B inhibitors-MAO-B inhibitors--adjunct Rx to L-dopa
-eg selegiline (eldepryl), rasagiline
-somewhat helpful in young, early in disease
-neuroprotective properties in animal models
only
Arch Neurology. 2002; 59:1937
Brought to you by
PD-medications
AnticholinergicsAnticholinergics—adjunct Rx to L-dopa, best
avoided in elderly
-acetylcholine (ACh) and dopamine in balance in
basal ganglia
-decrease Ach to balance decrease in L-dopa
-eg trihexyphenidyl (artane), benztropine
(cogentin), orphenadrine, procyclidine
(kemadrin)
-SE-confusion, hallucinations, dry mouth, blurred
vision, constipation, nausea, u. retention,
glaucoma
Brought to you by
PD-medications
Amantadine-adjunct to L-dopa, best
avoided in elderly
-for dyskinesias
-Antiviral agent—mechanism unknown
-NMDA-receptor antagonist properties-
interferes with excessive glutamate
-SE-livedo reticularis, ankle edema,
hallucinations
Brought to you by
PD- Medications
When do you stop the medications?
--ALWAYS taper gradually over days to
weeks to avoid NM-like syndrome
--unable to take meds (dysphagia)
--significant, intolerable SE impairing QOL
--end-stage--- “infection comes as a friend”
Brought to you by
OBJECTIVES
1. Illustrate medications and conditions that
may mimic PD
2. Describe the early symptoms of
Parkinson’s Disease (PD)
3. Discuss initiating and stopping
medications
Brought to you by
This platform has been started by Parveen
Kumar Chadha with the vision that nobody
should suffer the way he has suffered
because of lack and improper healthcare
facilities in India. We need lots of funds
manpower etc. to make this vision a reality
please contact us. Join us as a member for
a noble cause.
Brought to you by
Our views have increased the
mark of the 20,000
 Thank you viewers
 Looking forward for franchise,
collaboration, partners. Brought to you by
-011 25464531,-011 41425180,-011
66217387
+-91 9818308353,+-91
9818569476
othermotherindia@gmail.com
. - .www other mother in
: . . - - - ?https //www facebook com/pages/Other Mother Nursing Crusade/224235031114989 ref=hl
: . . ? _ _ _http //www linkedin com/profile/view id=326103341&trk=nav responsive tab profile
: .https //twitter com/othermotherindi
: . . -https //cparveen wix com/other mother
A WORLDWIDE MISSITION
Contact
Us:-
JOIN US
Saxbee Consultants Details :-www.parveenchadha.com
Brought to you by

Contenu connexe

Tendances

Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseaseguest27ee33
 
Management of advanced parkinson’s disease
Management of advanced parkinson’s diseaseManagement of advanced parkinson’s disease
Management of advanced parkinson’s diseaseAhmed Koriesh
 
Parkinson's disease n management
Parkinson's disease n managementParkinson's disease n management
Parkinson's disease n managementDr. Rupendra Bharti
 
Parkinson disease
Parkinson disease Parkinson disease
Parkinson disease Itsayesha
 
Management of parkinsons disease
Management of parkinsons diseaseManagement of parkinsons disease
Management of parkinsons diseasesadaf89
 
Parkinsonism Disease
Parkinsonism DiseaseParkinsonism Disease
Parkinsonism DiseaseVarunsj
 
Pharmacotherapy of parkinson disease
Pharmacotherapy of parkinson diseasePharmacotherapy of parkinson disease
Pharmacotherapy of parkinson diseaseSaleem Cology
 
Parkinsonism treatment
Parkinsonism treatmentParkinsonism treatment
Parkinsonism treatmentNaser Tadvi
 
Parkinson’s disease ( shobs )
Parkinson’s disease ( shobs )Parkinson’s disease ( shobs )
Parkinson’s disease ( shobs )Shobhit Shah
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Diseasetest
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s diseasevjcummins
 
Parkinsons disease o.j
Parkinsons disease o.jParkinsons disease o.j
Parkinsons disease o.jOkumu Jeremiah
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease000 07
 

Tendances (20)

Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Parkinson's diseases
Parkinson's diseasesParkinson's diseases
Parkinson's diseases
 
Management of advanced parkinson’s disease
Management of advanced parkinson’s diseaseManagement of advanced parkinson’s disease
Management of advanced parkinson’s disease
 
Parkinson's disease n management
Parkinson's disease n managementParkinson's disease n management
Parkinson's disease n management
 
Parkinson disease
Parkinson disease Parkinson disease
Parkinson disease
 
Management of parkinsons disease
Management of parkinsons diseaseManagement of parkinsons disease
Management of parkinsons disease
 
Parkinsonism Disease
Parkinsonism DiseaseParkinsonism Disease
Parkinsonism Disease
 
Pharmacotherapy of parkinson disease
Pharmacotherapy of parkinson diseasePharmacotherapy of parkinson disease
Pharmacotherapy of parkinson disease
 
Parkinson s disease
Parkinson s diseaseParkinson s disease
Parkinson s disease
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Parkinsonism treatment
Parkinsonism treatmentParkinsonism treatment
Parkinsonism treatment
 
Parkinson’s disease ( shobs )
Parkinson’s disease ( shobs )Parkinson’s disease ( shobs )
Parkinson’s disease ( shobs )
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinsons disease o.j
Parkinsons disease o.jParkinsons disease o.j
Parkinsons disease o.j
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 

En vedette

Parkinson's Disease Dementia
Parkinson's Disease DementiaParkinson's Disease Dementia
Parkinson's Disease Dementiawef
 
Parkinson's PT management
Parkinson's PT managementParkinson's PT management
Parkinson's PT managementRajin Tandan
 
Parkinson's Disease Presentation
Parkinson's Disease PresentationParkinson's Disease Presentation
Parkinson's Disease PresentationSteven Zuckerman
 
Parkinson's Disease sample
Parkinson's Disease sampleParkinson's Disease sample
Parkinson's Disease samplebtvssmedia
 
Uncovering the Hidden Symptoms of Parkinson’s Disease
Uncovering the Hidden Symptoms of Parkinson’s DiseaseUncovering the Hidden Symptoms of Parkinson’s Disease
Uncovering the Hidden Symptoms of Parkinson’s DiseaseGriswold Home Care
 
Stem cell research in Parkinson's Disease
Stem cell research  in Parkinson's DiseaseStem cell research  in Parkinson's Disease
Stem cell research in Parkinson's DiseaseVeena Shriram
 
Atypical parkinsonism
Atypical parkinsonismAtypical parkinsonism
Atypical parkinsonismSarath Menon
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseasemsrpt
 
Pharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's DiseasePharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's DiseaseHarshad Malve
 

En vedette (14)

Parkinson's Disease Dementia
Parkinson's Disease DementiaParkinson's Disease Dementia
Parkinson's Disease Dementia
 
Parkinson's PT management
Parkinson's PT managementParkinson's PT management
Parkinson's PT management
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
Parkinson's Disease Presentation
Parkinson's Disease PresentationParkinson's Disease Presentation
Parkinson's Disease Presentation
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
Parkinson's Disease sample
Parkinson's Disease sampleParkinson's Disease sample
Parkinson's Disease sample
 
Parkinsons
ParkinsonsParkinsons
Parkinsons
 
Uncovering the Hidden Symptoms of Parkinson’s Disease
Uncovering the Hidden Symptoms of Parkinson’s DiseaseUncovering the Hidden Symptoms of Parkinson’s Disease
Uncovering the Hidden Symptoms of Parkinson’s Disease
 
Stem cell research in Parkinson's Disease
Stem cell research  in Parkinson's DiseaseStem cell research  in Parkinson's Disease
Stem cell research in Parkinson's Disease
 
Atypical parkinsonism
Atypical parkinsonismAtypical parkinsonism
Atypical parkinsonism
 
Parkinson’s Disease
Parkinson’s DiseaseParkinson’s Disease
Parkinson’s Disease
 
Anti parkinsonian drugs
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugs
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Pharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's DiseasePharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's Disease
 

Similaire à Treatment of parkinson’s disease

Tues 8-00 Parkinson’s Disease- The Basics.pptx
Tues 8-00 Parkinson’s Disease- The Basics.pptxTues 8-00 Parkinson’s Disease- The Basics.pptx
Tues 8-00 Parkinson’s Disease- The Basics.pptxUmidjonSaparaliyev
 
Progressive supranuclear palsy presentation
Progressive supranuclear palsy presentationProgressive supranuclear palsy presentation
Progressive supranuclear palsy presentationDr. Md. Rashedul Islam
 
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdfPARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdfwajidullah9551
 
Assessment and Management of Parkinson.pptx
Assessment and Management of Parkinson.pptxAssessment and Management of Parkinson.pptx
Assessment and Management of Parkinson.pptxNimraFaraz
 
Rehabilitation_Management_of_Parkinsons_Disease.ppt
Rehabilitation_Management_of_Parkinsons_Disease.pptRehabilitation_Management_of_Parkinsons_Disease.ppt
Rehabilitation_Management_of_Parkinsons_Disease.pptSamiHassan39
 
Drug induced movement disorders
Drug induced movement disordersDrug induced movement disorders
Drug induced movement disordersPrerna Khar
 
Movement Disorders- M_Saidi- 21_01_20.pptx
Movement Disorders- M_Saidi- 21_01_20.pptxMovement Disorders- M_Saidi- 21_01_20.pptx
Movement Disorders- M_Saidi- 21_01_20.pptxMagicStudio
 
PARKINSON’S DISEASE PPT.pptx
PARKINSON’S DISEASE PPT.pptxPARKINSON’S DISEASE PPT.pptx
PARKINSON’S DISEASE PPT.pptxBharatiyaSiddharth
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Soujanya Pharm.D
 
1362404841 diab cranial auto neuropathy
1362404841 diab cranial auto neuropathy1362404841 diab cranial auto neuropathy
1362404841 diab cranial auto neuropathydfsimedia
 
1362571948 diab cranial auto neuropathy(1)
1362571948 diab cranial auto neuropathy(1)1362571948 diab cranial auto neuropathy(1)
1362571948 diab cranial auto neuropathy(1)dfsimedia
 
1362571948 diab cranial auto neuropathy
1362571948 diab cranial auto neuropathy1362571948 diab cranial auto neuropathy
1362571948 diab cranial auto neuropathydfsimedia
 
Dr Uma Nath - Parkinson's Disease in the Community
Dr Uma Nath - Parkinson's Disease in the CommunityDr Uma Nath - Parkinson's Disease in the Community
Dr Uma Nath - Parkinson's Disease in the CommunityCumbria Partnership
 

Similaire à Treatment of parkinson’s disease (20)

Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Tues 8-00 Parkinson’s Disease- The Basics.pptx
Tues 8-00 Parkinson’s Disease- The Basics.pptxTues 8-00 Parkinson’s Disease- The Basics.pptx
Tues 8-00 Parkinson’s Disease- The Basics.pptx
 
A Case of Progressive Supranuclear Palsy
A Case of Progressive Supranuclear PalsyA Case of Progressive Supranuclear Palsy
A Case of Progressive Supranuclear Palsy
 
Progressive supranuclear palsy presentation
Progressive supranuclear palsy presentationProgressive supranuclear palsy presentation
Progressive supranuclear palsy presentation
 
Neuro parkinsonism
Neuro parkinsonismNeuro parkinsonism
Neuro parkinsonism
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
 
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdfPARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
 
Parkinson disease
Parkinson diseaseParkinson disease
Parkinson disease
 
DBS for Parkinson's disease.
DBS for Parkinson's disease.DBS for Parkinson's disease.
DBS for Parkinson's disease.
 
Assessment and Management of Parkinson.pptx
Assessment and Management of Parkinson.pptxAssessment and Management of Parkinson.pptx
Assessment and Management of Parkinson.pptx
 
Rehabilitation_Management_of_Parkinsons_Disease.ppt
Rehabilitation_Management_of_Parkinsons_Disease.pptRehabilitation_Management_of_Parkinsons_Disease.ppt
Rehabilitation_Management_of_Parkinsons_Disease.ppt
 
Drug induced movement disorders
Drug induced movement disordersDrug induced movement disorders
Drug induced movement disorders
 
Movement Disorders- M_Saidi- 21_01_20.pptx
Movement Disorders- M_Saidi- 21_01_20.pptxMovement Disorders- M_Saidi- 21_01_20.pptx
Movement Disorders- M_Saidi- 21_01_20.pptx
 
PARKINSON’S DISEASE PPT.pptx
PARKINSON’S DISEASE PPT.pptxPARKINSON’S DISEASE PPT.pptx
PARKINSON’S DISEASE PPT.pptx
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
 
1362404841 diab cranial auto neuropathy
1362404841 diab cranial auto neuropathy1362404841 diab cranial auto neuropathy
1362404841 diab cranial auto neuropathy
 
1362571948 diab cranial auto neuropathy(1)
1362571948 diab cranial auto neuropathy(1)1362571948 diab cranial auto neuropathy(1)
1362571948 diab cranial auto neuropathy(1)
 
1362571948 diab cranial auto neuropathy
1362571948 diab cranial auto neuropathy1362571948 diab cranial auto neuropathy
1362571948 diab cranial auto neuropathy
 
Dr Uma Nath - Parkinson's Disease in the Community
Dr Uma Nath - Parkinson's Disease in the CommunityDr Uma Nath - Parkinson's Disease in the Community
Dr Uma Nath - Parkinson's Disease in the Community
 

Plus de Other Mother

`Selfie elbow' becoming new med condition
`Selfie elbow' becoming new med condition`Selfie elbow' becoming new med condition
`Selfie elbow' becoming new med conditionOther Mother
 
In us, one in nine men at risk of heart attack
In us, one in nine men at risk of heart attackIn us, one in nine men at risk of heart attack
In us, one in nine men at risk of heart attackOther Mother
 
Sun safety strategies for resort employees
Sun safety strategies for resort employeesSun safety strategies for resort employees
Sun safety strategies for resort employeesOther Mother
 
Transport operations
Transport operationsTransport operations
Transport operationsOther Mother
 
Aiims faculty wants hirings on hold
Aiims faculty wants hirings on holdAiims faculty wants hirings on hold
Aiims faculty wants hirings on holdOther Mother
 
Forced to leave us, jobless researcher drags centre to hc
Forced to leave us, jobless researcher drags centre to hcForced to leave us, jobless researcher drags centre to hc
Forced to leave us, jobless researcher drags centre to hcOther Mother
 
A project to marijuana abuse
A project to marijuana abuseA project to marijuana abuse
A project to marijuana abuseOther Mother
 
How pizza shops, steakhouses harm environment
How pizza shops, steakhouses harm environmentHow pizza shops, steakhouses harm environment
How pizza shops, steakhouses harm environmentOther Mother
 
Now, `guided chemo missiles' that target only cancer cells
Now, `guided chemo missiles' that target only cancer cellsNow, `guided chemo missiles' that target only cancer cells
Now, `guided chemo missiles' that target only cancer cellsOther Mother
 
`Not equal, some disabled need spl care'
`Not equal, some disabled need spl care'`Not equal, some disabled need spl care'
`Not equal, some disabled need spl care'Other Mother
 
Cloud over colon cancer blood test
Cloud over colon cancer blood testCloud over colon cancer blood test
Cloud over colon cancer blood testOther Mother
 
Gm mosquitoes to fight malaria
Gm mosquitoes to fight malariaGm mosquitoes to fight malaria
Gm mosquitoes to fight malariaOther Mother
 
India faces diabetes explosion
India faces diabetes explosionIndia faces diabetes explosion
India faces diabetes explosionOther Mother
 
Heart disease, cholesterol not linked
Heart disease, cholesterol not linkedHeart disease, cholesterol not linked
Heart disease, cholesterol not linkedOther Mother
 
1st `tampon disease' vaccine developed
1st `tampon disease' vaccine developed1st `tampon disease' vaccine developed
1st `tampon disease' vaccine developedOther Mother
 
Evolution of contraception
Evolution of  contraceptionEvolution of  contraception
Evolution of contraceptionOther Mother
 
Toxins in sippy cups a threat to babies
Toxins in sippy cups a threat to babiesToxins in sippy cups a threat to babies
Toxins in sippy cups a threat to babiesOther Mother
 
70% of indians eat non veg, but veg diet getting popular
70% of indians eat non veg, but veg diet getting popular70% of indians eat non veg, but veg diet getting popular
70% of indians eat non veg, but veg diet getting popularOther Mother
 

Plus de Other Mother (20)

`Selfie elbow' becoming new med condition
`Selfie elbow' becoming new med condition`Selfie elbow' becoming new med condition
`Selfie elbow' becoming new med condition
 
In us, one in nine men at risk of heart attack
In us, one in nine men at risk of heart attackIn us, one in nine men at risk of heart attack
In us, one in nine men at risk of heart attack
 
Sun safety strategies for resort employees
Sun safety strategies for resort employeesSun safety strategies for resort employees
Sun safety strategies for resort employees
 
Transport operations
Transport operationsTransport operations
Transport operations
 
Aiims faculty wants hirings on hold
Aiims faculty wants hirings on holdAiims faculty wants hirings on hold
Aiims faculty wants hirings on hold
 
Forced to leave us, jobless researcher drags centre to hc
Forced to leave us, jobless researcher drags centre to hcForced to leave us, jobless researcher drags centre to hc
Forced to leave us, jobless researcher drags centre to hc
 
A project to marijuana abuse
A project to marijuana abuseA project to marijuana abuse
A project to marijuana abuse
 
How pizza shops, steakhouses harm environment
How pizza shops, steakhouses harm environmentHow pizza shops, steakhouses harm environment
How pizza shops, steakhouses harm environment
 
Now, `guided chemo missiles' that target only cancer cells
Now, `guided chemo missiles' that target only cancer cellsNow, `guided chemo missiles' that target only cancer cells
Now, `guided chemo missiles' that target only cancer cells
 
`Not equal, some disabled need spl care'
`Not equal, some disabled need spl care'`Not equal, some disabled need spl care'
`Not equal, some disabled need spl care'
 
Cloud over colon cancer blood test
Cloud over colon cancer blood testCloud over colon cancer blood test
Cloud over colon cancer blood test
 
Gm mosquitoes to fight malaria
Gm mosquitoes to fight malariaGm mosquitoes to fight malaria
Gm mosquitoes to fight malaria
 
Sea of trash
Sea of trashSea of trash
Sea of trash
 
India faces diabetes explosion
India faces diabetes explosionIndia faces diabetes explosion
India faces diabetes explosion
 
Heart disease, cholesterol not linked
Heart disease, cholesterol not linkedHeart disease, cholesterol not linked
Heart disease, cholesterol not linked
 
1st `tampon disease' vaccine developed
1st `tampon disease' vaccine developed1st `tampon disease' vaccine developed
1st `tampon disease' vaccine developed
 
Stress and coping
Stress and copingStress and coping
Stress and coping
 
Evolution of contraception
Evolution of  contraceptionEvolution of  contraception
Evolution of contraception
 
Toxins in sippy cups a threat to babies
Toxins in sippy cups a threat to babiesToxins in sippy cups a threat to babies
Toxins in sippy cups a threat to babies
 
70% of indians eat non veg, but veg diet getting popular
70% of indians eat non veg, but veg diet getting popular70% of indians eat non veg, but veg diet getting popular
70% of indians eat non veg, but veg diet getting popular
 

Dernier

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 

Dernier (20)

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 

Treatment of parkinson’s disease

  • 1. DIAGNOSIS & TREATMENT OF PARKINSON’S DISEASE May 7, 2008 Sadhana Prasad Symposium on Changes and Challenges in Geriatric Care Brought to you by
  • 2. Disclosures • Work with various pharmaceutical companies intermittently • Honorarium will be donated Brought to you by
  • 5. OBJECTIVES 1. Illustrate medications and conditions that may mimic PD 2. Describe the early symptoms of Parkinson’s Disease (PD) 3. Discuss initiating and stopping medications Brought to you by
  • 6. Parkinson’s Disease Characterized by: (Slow,Stiff,Shaky) • Bradykinesia * • Rigidity * • Rest tremor--3-6Hz pill-rolling (absent 1/3) • Postural instability Brought to you by
  • 7. Parkinson’s Disease (PD) • First description 1817 Parkinson, James An Essay on the Shaking Palsy, Sherwood, Neely, and Jones, London • Progressive neurodegenerative disease • Affects ages 40 onwards, mean age at diagnosis 70.5 • Complex disorder with motor, non-motor, neuropsychiatric features Brought to you by
  • 8. Disease vs Syndrome • Disease = a morbid process having characteristic symptoms; pathology, etiology, and prognosis may be known • Syndrome = a set of symptoms occurring together; different etiologies but similar presentation Brought to you by
  • 9. Parkinson’s Syndromes Metabolic causes-- • Hypothyroidism • Hypoparathyroidism • Alcohol withdrawl (pseudoparkinsonism) • Chronic liver failure • Wilson’s disease Brought to you by
  • 10. P. Syndromes Medications**/chemicals— • neuroleptics (typicals more than the atypicals), • SSRI (selective serotonin reuptake inhibitors), • metoclopromide/maxeran, • Reserpine, • MPTP, • in Methcathinone (ephedrone) users – high plasma Manganese levels (NEJM Mar 6, 2008) • CO, cyanide, organic solvents, carbon disulfide Brought to you by
  • 11. P. Syndromes Structural Causes— • Strokes • Tumors • Chronic subdurals • NPH (Normal Pressure Hydrocephalus) Brought to you by
  • 12. P.Syndromes Lewy Body spectrum of Diseases (DLB=Dementia with LB)--- ---early onset visual (or other) hallucinations ---fluctuating cognitive abilities ---sleep disorders ---neuroleptic sensitivity, even to atypicals Brought to you by
  • 13. P. Syndromes PSP (progressive supranuclear palsy)—or Steeles Richardson Olszewski Syndrome ---gaze abnormalities ---postural instability, early unexplained falls ---bulbar features—dysphonia, dysarthria, dysphagia ---rapidly progressive---median 6 yrs. Brought to you by
  • 14. P. Syndromes CBD (cortico basal degeneration)--- ---Asymmetric parkinsonism ---postural instability ---ideomotor apraxia ---aphasia ---alien limb phenomenon ---impaired cortical sensations Brought to you by
  • 15. P. Syndromes Multi System Atrophy-- (alpha-synuclein + glial cytoplasmic inclusions, autonomic dysfunction, pyramidal signs) • Shy Drager Syndrome, • Olivopontocerebellar atrophy, • Striatonigral degeneration Brought to you by
  • 16. P. Syndromes Other Neurodegenerative Disorders— • Alzheimer’s Disease, later stages** • Huntington’s Disease (rigid form) • Frontotemporal Dementia with Parkinsonism, Chromosome-17 linked (FTDP-17) • Spinocerebellar ataxias Brought to you by
  • 17. P. Syndromes Infections--- • encephalitis • HIV/AIDS • Neurosyphilis • Toxoplasmosis • CJD (Creuzfeld Jakob)--prion disease • Progressive multifocal leukoencephalopathy Brought to you by
  • 18. P. Syndrome Essential Tremor--- ---action tremor (not rest tremor) ---more rapid (greater than 3-6 Hz) ---usually hands, but can also affect legs, head/chin, voice, trunk ---can present with falls if legs and trunk involved Brought to you by
  • 20. P. Dis -- Diagnosis • A clinical diagnosis • Cardinal features: Bradykinesia, rigidity • Trial of sinemet (Levodopa/carbidopa) • Confirmatory test: neuropathologic (autopsy) Brought to you by
  • 21. P. Disease-Diagnosis • 1/3 will not respond to levodopa therapy • 1/5 with P. Syndrome will respond to levodopa ---Follow- up with time needed to clarify diagnosis Brought to you by
  • 22. P. Disease---Diagnosis Minimum therapeutic dose: ---300mg levodopa per day in divided doses ---can be lower in biologically old old ---vast majority will need 400-600mg levodopa daily to achieve significant benefit Brought to you by
  • 23. P. Disease- Diagnosis Consider alternative diagnosis if: • Early falls (postural instability) • Poor response to levodopa • Dysautonomia (urinary retention/atonic bladder, incontinence, orthostatic hypotension, impotence) • No rest tremor (in 1/3) Brought to you by
  • 24. P. Disease-Diagnosis Alternative Diagnosis cont’d… • Cerebellar signs • Positive Babinski • Apraxia • Gaze abnormailities • Dementia concurrently with Parkinsonism • Strokes Brought to you by
  • 25. P. Disease INVESTIGATIONS: • TSH • Calcium, albumin • CT head Brought to you by
  • 26. OBJECTIVES 1. Illustrate medications and conditions that may mimic PD 2. Describe the early symptoms of Parkinson’s Disease (PD) 3. Discuss initiating and stopping medications Brought to you by
  • 27. PD- CASE • Mr AB, married, active farmer, stressed care-giver • Drove his wife to the clinic, wife to see me re agitated dementia • One son also attended • Mr AB –stressed care-giver, on paxil (SSRI) Brought to you by
  • 28. PD- case Mr. AB--- stressed caregiver • Slightly flexed posture • Slightly bradykinetic • Slightly diminished facial expression • No difficulty turning, getting in/out of armless chair Brought to you by
  • 29. PD-case “I don’t have Parkinson’s Disease!!” Brought to you by
  • 30. PD- case Mr. AB--- • 1 month later, referred re ? PD?? • CT head, TSH, Ca normal • Slowing down x 1 yr, hypophonia, denied trouble turning in bed but took 5 tries in clinic, trouble getting out of soft chair, stopped taking baths x 3 years, mild rest tremor R hand, trouble doing up buttons and laces Brought to you by
  • 31. IADL Instrumental Activities of Daily Living • S shopping • H housework • A accounting • F food preparation • T transportation Brought to you by
  • 32. ADL Activities of Daily Living • D dressing • E eating • A ambulation • T toiletting • H hygiene Brought to you by
  • 33. PD- case 1 Brought to you by
  • 35. PD –Case 1 Diagnosis: Parkinson’s disease ---Hoehn & Yahr’s** stage 2 Brought to you by
  • 36. Hoehn and Yahr scale • 1. Unilateral involvement only, usually with minimal or no functional disability • 2. Bilateral or midline involvement without impairment of balance • 3. Bilateral disease; mild to moderate disability with impaired postural reflexes; physically independent • 4. Severely disabling disease; still able to walk or stand unassisted • 5. Confinement to bed or wheelchair unless aided Hoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17:427. Brought to you by
  • 37. PD- case 1 • MTO notified, “not to cancel license” • Paxil * • Sinemet regular 100/25 mg ½ tid, increase by ½ weekly till 1 tid • Calcium and vitamin D3 • 2 months later, smiling, clock better, moving better, still flexed, no fallsBrought to you by
  • 39. PD—other issues • Depression • Dementia • Driving • Falls • Neuropsychiatric features • “slowing down of thought processes” (the clock in Mr AB) • Constipation Brought to you by
  • 41. OBJECTIVES 1. Illustrate medications and conditions that may mimic PD 2. Describe the early symptoms of Parkinson’s Disease (PD) 3. Discuss initiating and stopping medications Brought to you by
  • 42. PD--Treatment • Geared towards mobility—levodopa, dopamine agonists, MAO B inhibitors • Rest tremor, cosmetic—anticholinergics (may worsen cognition) • Postural imbalance—no pharmacological treatment; exercise, gait aids, prevent fractures (Ca, Vit D3, +/- bisphosphonates) • Dyskinesias-- ?amantadine (no clear evidence) Almeida,QJ, Recent Patents on CNS Drug Discovery, 2008:3, 5--54 Brought to you by
  • 43. PD--Which pharmaceutical? In Elderly-- • Levodopa/ carbidopa (sinemet) – regular vs CR (controlled release) or Levodopa/ benserazide (prolopa) – regular vs HBS • COMT- inhibitor– entacapone (comtan)Brought to you by
  • 44. PD- medications LevodopaLevodopa • Well-established, for bradykinesia and rigidity • SE: nausea, orthostatic hypotension • Combined with peripheral decarboxylase inhibitor (carbidopa, benserazide) to prevent conversion to dopamine in the periphery before it crosses blood brain barrier Brought to you by
  • 45. PD- medications Levodopa (l-dopa) -- l-dopa / carbidopa = sinemet reg. or CR -- l-dopa / benserazide = prolopa, medopar or medopar HBS • Competes with amino acids from protein for GI absorption • Regular-- before meals, quick in quick out, T1/2 = 90 min • CR--- With meals,Controlled Release, slow in slow out, need 30% more to achieve same effect as reg. dose, erratic absorption in elderly Brought to you by
  • 46. PD-medications L-dopa cont’d • SE- Nausea (Rx Domperidone) -Hallucinations (Rx lower dose, atypical n neuroleptics) -somnolence, confusion, agitation -motor fluctuations- after sev yrs of Rx Brought to you by
  • 47. PD- medications L-dopa cont’d • Motor fluctuations (in 50%, after 5-10yrs) -wearing-off– Rx COMT – inhibitor*, ?CR -dyskinesias –(??Rx amantadine??) -dystonias -variety of complex fluctuations in motor function Brought to you by
  • 48. PD- medications L-dopa cont’d • Discontinuation— - gradually –over weeks, - to prevent malignant neuroleptic like syndrome or akinetic crisis Brought to you by
  • 49. PD-medications L-dopa cont’d • Dopaminergic dysregulation syndrome (DDS)— tolerance to mood elevating effects - Compulsive use of dopaminergic drugs - Early onset males - Cyclical mood disorder - Impulse control disorder (hypersexuality, pathologic gambling) Giovannoni, G, Hedonistic homeostatic dysregulation…J. Neurol Neurosurg Psychiatry 2000; 68:243 Brought to you by
  • 50. PD- medications COMT – inhibitorCOMT – inhibitor -Catechol-O-Methyl Transferase Inhibitor -((eg Tolcapone (Tasmar)---off market due to fulminant hepatitis causing 3 deaths)) -eg Entacapone (Comtan) -for wearing-off at end-of-dose of L-dopa -dose 200mg-1600mg, divided, daily, with L-dopa -SE-diarrhea in 5%, due to increased dopaminergic stimulation from L-dopa availability Brought to you by
  • 51. PD-medications Dopamine Agonists: adjunct Rx to L-dopa. -Ergotamines—bromocriptine, ((pergolide)), ((cabergoline)) SE-same as L-dopa, uncommon Raynaud’s, erythromelalgia, retroperitoneal/pulmonary fibrosis -Non-Ergot—pramipexole, ropinirole, ((transdermal rotigotine)) SE—same as L-dopa, Sudden somnolence – caution with driving Brought to you by
  • 52. PD-medications MAO-B inhibitors-MAO-B inhibitors--adjunct Rx to L-dopa -eg selegiline (eldepryl), rasagiline -somewhat helpful in young, early in disease -neuroprotective properties in animal models only Arch Neurology. 2002; 59:1937 Brought to you by
  • 53. PD-medications AnticholinergicsAnticholinergics—adjunct Rx to L-dopa, best avoided in elderly -acetylcholine (ACh) and dopamine in balance in basal ganglia -decrease Ach to balance decrease in L-dopa -eg trihexyphenidyl (artane), benztropine (cogentin), orphenadrine, procyclidine (kemadrin) -SE-confusion, hallucinations, dry mouth, blurred vision, constipation, nausea, u. retention, glaucoma Brought to you by
  • 54. PD-medications Amantadine-adjunct to L-dopa, best avoided in elderly -for dyskinesias -Antiviral agent—mechanism unknown -NMDA-receptor antagonist properties- interferes with excessive glutamate -SE-livedo reticularis, ankle edema, hallucinations Brought to you by
  • 55. PD- Medications When do you stop the medications? --ALWAYS taper gradually over days to weeks to avoid NM-like syndrome --unable to take meds (dysphagia) --significant, intolerable SE impairing QOL --end-stage--- “infection comes as a friend” Brought to you by
  • 56. OBJECTIVES 1. Illustrate medications and conditions that may mimic PD 2. Describe the early symptoms of Parkinson’s Disease (PD) 3. Discuss initiating and stopping medications Brought to you by
  • 57. This platform has been started by Parveen Kumar Chadha with the vision that nobody should suffer the way he has suffered because of lack and improper healthcare facilities in India. We need lots of funds manpower etc. to make this vision a reality please contact us. Join us as a member for a noble cause. Brought to you by
  • 58. Our views have increased the mark of the 20,000  Thank you viewers  Looking forward for franchise, collaboration, partners. Brought to you by
  • 59. -011 25464531,-011 41425180,-011 66217387 +-91 9818308353,+-91 9818569476 othermotherindia@gmail.com . - .www other mother in : . . - - - ?https //www facebook com/pages/Other Mother Nursing Crusade/224235031114989 ref=hl : . . ? _ _ _http //www linkedin com/profile/view id=326103341&trk=nav responsive tab profile : .https //twitter com/othermotherindi : . . -https //cparveen wix com/other mother A WORLDWIDE MISSITION Contact Us:- JOIN US Saxbee Consultants Details :-www.parveenchadha.com Brought to you by

Notes de l'éditeur

  1. **Case of Cathy Dawson, with late stage dementiaan needed 3+hrs of care daily; my reluctance to add sin, but did very well and was able to return to ret home